Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06778278 · ClinicalTrials.gov registry record · NA
Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans
A NA study of Suicidal Ideation and Mental Health, sponsored by RTI International.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06778278 is a NA study of Suicidal Ideation and Mental Health that is actively recruiting participants, run by RTI International. The registered enrollment target is 40 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06778278, a NA study of Suicidal Ideation and Mental Health, is actively recruiting participants, sponsored by RTI International.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to develop and pilot a program designed to improve mental health outcomes and reduce suicide risk during the transition from military to civilian life. It is hypothesized that the Transition Health and Resilience through Valued Experiences (THRiVE) program, to be developed as part of this study, will meet participant recruitment, retention, and satisfaction benchmarks (primary outcomes) and show positive preliminary effects on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning outcomes (secondary outcomes). The specific aims of this study are to: 1. Develop a small-group, peer-led, cross-cutting prevention program for newly separated veterans (NSVs) called THRiVE and 2. Evaluate the feasibility, acceptability, and preliminary effects of the THRiVE program on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning outcomes. Up to 40 NSVs participating in this Stage 1 pilot study will complete validated self-report measures at baseline, immediately after completing the THRiVE program (post-THRiVE), and 3 months after completing the THRiVE program (follow-up). The duration of a participant's time in the study is anticipated to be 5 months.
Conditions Studied
Interventions
- BEHAVIORAL Transition Health and Resilience through Valued Experiences (THRiVE) Program
Study Locations (1)
North Carolina
- RTI International - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-07-30 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06778278
The ClinicalTrials.gov registry entry for NCT06778278 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (85% lower). The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Transition Health and Resilience through Valued Experiences (THRiVE) Program is the first listed.
NCT06778278 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06778278 about?
NCT06778278 is a clinical study titled "Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans". The objective of this study is to develop and pilot a program designed to improve mental health outcomes and reduce suicide risk during the transition from military to civilian life. It is hypothesized that the Transition Health and Resilience through Valued Experiences (THRiVE) program, to be devel...
What is the current status of trial NCT06778278?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-30. Estimated completion is 2026-10-31.
What conditions does trial NCT06778278 study?
This clinical trial studies the following conditions: Suicidal Ideation, Mental Health, Alcohol Misuse, Military Transition, Community Reintegration.
What interventions are being tested in trial NCT06778278?
The interventions under investigation include: Transition Health and Resilience through Valued Experiences (THRiVE) Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06778278?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06778278 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.